Argenx Se (ARGX) Interest Expenses (2019 - 2026)
Argenx Se's (ARGX) quarterly Interest Expenses came in at $448000.0 in Q2 2022, down 87.41% YoY from $3.6 million in Q2 2021, and up 147.01% on a QoQ basis from -$953000.0 in Q1 2022.
Analysis
Argenx Se (ARGX) Interest Expenses (2019 - 2026) Analysis & Trends
Argenx Se (ARGX) has 3 years of Interest Expenses data on file, last reported at $448000.0 in Q2 2022.
- Quarterly Interest Expenses fell 87.41% year-over-year to $448000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $448000.0 (down 82.8% YoY) and the FY2025 annual result came in at $4.1 million, up 65.67% from the prior year.
- Interest Expenses improved to $448000.0 in Q2 2022, from -$953000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $3.6 million in Q2 2021 to a low of -$1.2 million in Q1 2021.
- A 3-year average of $342842.6 and a median of $94527.9 in 2019 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 19.51% in 2022, down 87.41% in 2022.
- Tracing ARGX's Interest Expenses over 3 years: stood at $231339.5 in 2019, then surged by 1437.57% to $3.6 million in 2021, then plunged by 87.41% to $448000.0 in 2022.
- The last three Interest Expenses figures came in at $448000.0 (Q2 2022), -$953000.0 (Q1 2022), and $3.6 million (Q2 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 582,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | -828,000.00 |
| Sep 30, 2025 | -993,000.00 |
| Jun 30, 2025 | -1.13 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | -704,000.00 |
| Sep 30, 2024 | -676,000.00 |
| Jun 30, 2024 | -572,000.00 |
| Mar 31, 2024 | -512,000.00 |
| Dec 31, 2023 | -280,000.00 |
| Sep 30, 2023 | -231,000.00 |
| Jun 30, 2023 | -207,000.00 |
| Mar 31, 2023 | -188,000.00 |
| Dec 31, 2022 | -990,000.00 |
| Sep 30, 2022 | -785,000.00 |
| Jun 30, 2022 | -1.18 Mn |
| Mar 31, 2022 | -953,000.00 |
| Dec 31, 2021 | -1.10 Mn |
| Sep 30, 2021 | -1.10 Mn |